Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Vik Chopra is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/20/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/28/2025 | SOLV | Buy Now | Solventum | $75.63 | -0.83% | Vik Chopra38% | $73 → $75 | Maintains | Equal-Weight | Get Alert |
| 02/28/2025 | XRAY | Buy Now | Dentsply Sirona | $15.66 | 21.33% | Vik Chopra38% | $20 → $19 | Maintains | Equal-Weight | Get Alert |
| 02/26/2025 | MASI | Buy Now | Masimo | $172.74 | 18.68% | Vik Chopra38% | $193 → $205 | Maintains | Overweight | Get Alert |
| 02/21/2025 | GMED | Buy Now | Globus Medical | $73.34 | 26.81% | Vik Chopra38% | $95 → $93 | Maintains | Overweight | Get Alert |
| 02/14/2025 | ALGN | Buy Now | Align Tech | $166.14 | 53.49% | Vik Chopra38% | → $255 | Initiates | → Overweight | Get Alert |
| 02/14/2025 | XRAY | Buy Now | Dentsply Sirona | $15.66 | 27.71% | Vik Chopra38% | → $20 | Initiates | → Equal-Weight | Get Alert |
| 02/14/2025 | HSIC | Buy Now | Henry Schein | $70.84 | 12.93% | Vik Chopra38% | → $80 | Initiates | → Equal-Weight | Get Alert |
| 02/06/2025 | CNMD | Buy Now | Conmed | $58.91 | 18.83% | Vik Chopra38% | $74 → $70 | Maintains | Equal-Weight | Get Alert |
| 02/06/2025 | NVST | Buy Now | Envista Holdings | $17.00 | 23.53% | Vik Chopra38% | $20 → $21 | Maintains | Equal-Weight | Get Alert |
| 12/11/2024 | GMED | Buy Now | Globus Medical | $73.34 | 29.53% | Vik Chopra38% | $88 → $95 | Maintains | Overweight | Get Alert |
| 12/11/2024 | MASI | Buy Now | Masimo | $172.74 | 11.73% | Vik Chopra38% | $171 → $193 | Maintains | Overweight | Get Alert |
| 11/13/2024 | NPCE | Buy Now | NeuroPace | $11.75 | 10.64% | Vik Chopra38% | $15 → $13 | Maintains | Overweight | Get Alert |
| 11/06/2024 | GMED | Buy Now | Globus Medical | $73.34 | 19.99% | Vik Chopra38% | $78 → $88 | Maintains | Overweight | Get Alert |
| 11/06/2024 | MASI | Buy Now | Masimo | $172.74 | -1.01% | Vik Chopra38% | $160 → $171 | Maintains | Overweight | Get Alert |
| 10/08/2024 | NVST | Buy Now | Envista Holdings | $17.00 | 17.65% | Vik Chopra38% | → $20 | Initiates | → Equal-Weight | Get Alert |
| 08/14/2024 | NPCE | Buy Now | NeuroPace | $11.75 | 27.66% | Vik Chopra38% | $20 → $15 | Maintains | Overweight | Get Alert |
| 08/09/2024 | SOLV | Buy Now | Solventum | $75.63 | -15.38% | Vik Chopra38% | $69 → $64 | Maintains | Equal-Weight | Get Alert |
| 08/07/2024 | GMED | Buy Now | Globus Medical | $73.34 | 6.35% | Vik Chopra38% | $60 → $78 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/01/2024 | CNMD | Buy Now | Conmed | $58.91 | 20.52% | Vik Chopra38% | $77 → $71 | Maintains | Equal-Weight | Get Alert |
| 08/01/2024 | ATEC | Buy Now | Alphatec Holdings | $9.54 | 99.16% | Vik Chopra38% | $26 → $19 | Maintains | Overweight | Get Alert |
| 05/07/2024 | IART | Buy Now | Integra Lifesciences | $22.82 | 9.55% | Vik Chopra38% | $45 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/25/2024 | CNMD | Buy Now | Conmed | $58.91 | 30.71% | Vik Chopra38% | $98 → $77 | Maintains | Equal-Weight | Get Alert |
| 04/08/2024 | SOLV | Buy Now | Solventum | $75.63 | -8.77% | Vik Chopra38% | → $69 | Initiates | → Equal-Weight | Get Alert |
| 03/25/2024 | MASI | Buy Now | Masimo | $172.74 | -7.38% | Vik Chopra38% | $117 → $160 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/23/2024 | ENOV | Buy Now | Enovis | $39.43 | 100.36% | Vik Chopra38% | $73 → $79 | Maintains | Overweight | Get Alert |
| 11/08/2023 | MASI | Buy Now | Masimo | $172.74 | -53.11% | Vik Chopra38% | $110 → $81 | Maintains | Equal-Weight | Get Alert |
| 09/15/2023 | GMED | Buy Now | Globus Medical | $73.34 | -20.92% | Vik Chopra38% | $63 → $58 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | MASI | Buy Now | Masimo | $172.74 | -36.32% | Vik Chopra38% | $126 → $110 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | GMED | Buy Now | Globus Medical | $73.34 | -14.1% | Vik Chopra38% | $61 → $63 | Maintains | Equal-Weight | Get Alert |
| 07/18/2023 | MASI | Buy Now | Masimo | $172.74 | -27.06% | Vik Chopra38% | $173 → $126 | Maintains | Equal-Weight | Get Alert |
| 07/10/2023 | MASI | Buy Now | Masimo | $172.74 | 0.15% | Vik Chopra38% | → $173 | Initiates | → Equal-Weight | Get Alert |
| 05/12/2023 | ENOV | Buy Now | Enovis | $39.43 | 69.92% | Vik Chopra38% | $55 → $67 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/22/2023 | GMED | Buy Now | Globus Medical | $73.34 | -16.83% | Vik Chopra38% | $67 → $61 | Maintains | Equal-Weight | Get Alert |
| 02/10/2023 | NUVA | Buy Now | NuVasive | — | — | Vik Chopra38% | $47 → $57.72 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/10/2023 | GMED | Buy Now | Globus Medical | $73.34 | -8.64% | Vik Chopra38% | $82 → $67 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/12/2022 | GMED | Buy Now | Globus Medical | $73.34 | 11.81% | Vik Chopra38% | $74 → $82 | Maintains | Overweight | Get Alert |
| 11/10/2022 | NUVA | Buy Now | NuVasive | — | — | Vik Chopra38% | $62 → $47 | Maintains | Overweight | Get Alert |
| 10/26/2022 | ENOV | Buy Now | Enovis | $39.43 | 34.42% | Vik Chopra38% | $60 → $53 | Maintains | Equal-Weight | Get Alert |
